Cervical Degenerative Disc Disorder
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
NuVasiveCA - San Diego
3 programsSimplify DiscN/A1 trial
Simplify DiscN/A1 trial
Simplify DiscN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
NuVasiveSimplify Disc
NuVasiveSimplify Disc
NuVasiveSimplify Disc
Clinical Trials (3)
Total enrollment: 618 patients across 3 trials
Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc
Start: Aug 2021Est. completion: Jan 2024291 patients
N/ACompleted
Post-Approval Study Protocol for the Simplify Cervical Artificial Disc
Start: Jan 2021Est. completion: Apr 2023145 patients
N/ACompleted
Investigation of the Two Level Simplify® Cervical Artificial Disc
Start: Apr 2017Est. completion: Mar 2022182 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.